Progress and Prospects of Diagnosis and Treatment Techniques for Acute Ischemic Stroke

doi:10.3969/j.issn.1673-5765.2024.09.001

Abstract

Abstract: Acute ischemic stroke (AIS) is one of the leading causes of disability and death among adults worldwide. In recent years, significant advancements have been made in the diagnosis and treatment of AIS, driven by a deeper understanding of its pathophysiological mechanisms and innovations in therapeutic methods. These advancements range from multimodal imaging to the applications of biomarkers, from intravenous thrombolysis to mechanical thrombectomy, from immunomodulation to neuroprotective strategies, and from stem cell therapy to nanomedicine. The field has evolved from drug treatments alone to comprehensive therapeutic models that combine medication with mechanical thrombectomy. The management of AIS is increasingly moving towards individualized, precise, effective, and holistic approaches. Through applying diverse and advanced diagnostic and therapeutic techniques, the early diagnosis level and treatment efficacy of AIS can be enhanced, and ultimately the patients’ outcomes can be improved.

Key words: Acute ischemic stroke; Diagnosis; Treatment; Technique; Method; Progress

摘要： 急性缺血性卒中是全球成人残疾和死亡的主要原因之一。随着对急性缺血性卒中病理生理机制的深入理解和对诊疗方法的创新，近年来急性缺血性卒中诊疗技术取得显著进展。从多模态影像到生物标志物的应用，从静脉溶栓到机械取栓，从免疫调节到神经保护策略，从干细胞疗法到纳米医学，从最初的单纯药物治疗发展到药物结合机械取栓的综合性治疗，急性缺血性卒中诊治领域正朝着个体化、精准化、有效和全面管理的方向发展。应用多样化的先进诊疗技术和方法，有助于提高急性缺血性卒中的早期诊断水平和治疗效果，最终改善患者预后。

关键词: 急性缺血性卒中; 诊断; 治疗; 技术; 方法; 进展

CLC Number:

CAO Liming, REN Lijie. Progress and Prospects of Diagnosis and Treatment Techniques for Acute Ischemic Stroke[J]. Chinese Journal of Stroke, 2024, 19(9): 983-989.

曹黎明, 任力杰. 急性缺血性卒中诊疗技术的进展与展望[J]. 中国卒中杂志, 2024, 19(9): 983-989.

References

[1] LI S，FISHER M. Improving large animal ischemic stroke models for translational studies in the era of recanalization[J/OL]. Stroke，2023，54（1）：e16-e19[2024-08-01]. https://doi.org/10.1161/STROKEAHA.122.041354.

[2] BARRETT K M，LAL B K，MESCHIA J F. Stroke：advances in medical therapy and acute stroke intervention[J/OL]. Curr Cardiol Rep，2015，17（10）：79[2024-08-01]. https://doi.org/10.1007/s11886-015-0637-1.

[3] TEDYANTO E，TINI K，PRAMANA N. Magnetic resonance imaging in acute ischemic stroke[J/OL]. Cureus，2022，14（7）：e27224[2024-08-01]. https://doi.org/10.7759/cureus.27224.

[4] LASOŃ W，JANTAS D，LEŚKIEWICZ M，et al. Vitamin D3 and ischemic stroke：a narrative review[J/OL]. Antioxidants（Basel），2022，11（11）：2120[2024-08-01]. https://doi.org/10.3390/antiox11112120.

[5] RAMADHONI P D. Mechanical thrombectomy as the treatment of choice for ischemic stroke large vessel acocclusion[J]. Arkus，2021，4（1）：191-194.

[6] PACHAY A J Z，CHáVEZ E V E，CARRERA W A C，et al. Emerging therapies in the management of acute ischemic stroke：innovative approaches and clinical outcomes—a comprehensive literature review[J]. International Journal of Medical Science and Clinical Research Studies，2024，4（3）：581-588.

[7] GONG P，ZHANG W，HE Y，et al. Classification and characteristics of mesenchymal stem cells and its potential therapeutic mechanisms and applications against ischemic stroke[J/OL]. Stem Cells Int，2021，2021：2602871[2024-08-01]. https://doi.org/10.1155/2021/2602871.

[8] KIDWELL C S，HSIA A W. Imaging of the brain and cerebral vasculature in patients with suspected stroke：advantages and disadvantages of CT and MRI[J]. Curr Neurol Neurosci Rep，2006，6（1）：9-16.

[9] BANG O Y，CHUNG J W，SON J P，et al. Multimodal MRI-based triage for acute stroke therapy：challenges and progress[J/OL]. Front Neurol，2018，9：586[2024-08-01]. https://doi.org/10.3389/fneur.2018.00586.

[10] ALBERS G W，THIJS V N，WECHSLER L，et al. Magnetic resonance imaging profiles predict clinical response to early reperfusion：the diffusion and perfusion imaging evaluation for understanding stroke evolution（DEFUSE）study[J]. Ann Neurol，2006，60（5）：508-517.

[11] NEZU T，MUKAI T，UEMURA J，et al. Multiple infarcts are associated with long-term stroke recurrence and all-cause mortality in cryptogenic stroke patients[J]. Stroke，2016，47（9）：2209-2215.

[12] CAO L M，HUANG X M，WANG H L. Relevance of small right-to-left shunt in contrast-enhanced transcranial Doppler in young and middle-aged patients with cryptogenic stroke：a report of two cases and literature review[J]. Int J Neurosci，2022，132（11）：1118-1122.

[13] YAO Q Y，XIONG H H，ZHANG D X，et al. Synchronous multimode ultrasound for assessing right-to-left shunt：a prospective clinical study[J/OL]. Front Neurol，2023，14：1148846[2024-08-01]. https://doi.org/10.3389/fneur.2023.1148846.

[14] 姚漫涓，龙霞，任力杰，等. 同步经颅多普勒发泡试验联合对比增强经胸超声心动图在右向左分流中应用的研究进展[J]. 中西医结合心脑血管病杂志，2023，21（20）：3765-3767.

YAO M J，LONG X，REN L J，et al. Research progress on simultaneous contrast-enhanced transcranial Doppler foam test combined with contrast transthoracic echocardiography in right-to-left shunt[J]. Chinese Journal of Integrative Medicine on Cardio-Cerebrovascular Disease，2023，21（20）：3765-3767.

[15] LIU R J，YU X D，ZHANG L P，et al. Computed tomography（CT）imaging evaluation of integrated traditional Chinese medicine cooperative therapy in treating acute cerebral infarction：a randomized controlled trial[J/OL]. Medicine（Baltimore），2020，99（18）：e19998[2024-08-01]. https://doi.org/10.1097/MD.0000000000019998.

[16] GONZáLEZ-AQUINES A，MORENO-ANDRADE T，GóNGORA-RIVERA F，et al. The role of tractography in ischemic stroke：a review of the literature[J]. Medicina Universitaria，2018，20（4）：161-165.

[17] LI X T，YUAN J L，HU W L. Vertebrobasilar artery dissection manifesting as Millard-Gubler syndrome in a young ischemic stroke patient：a case report[J]. World J Clin Cases，2019，7（1）：73-78.

[18] FU P C，WANG J Y，SU Y，et al. Intravascular ultrasonography assisted carotid artery stenting for treatment of carotid stenosis：two case reports[J]. World J Clin Cases，2023，11（29）：7127-7135.

[19] ROBBA C，CARDIM D，SEKHON M，et al. Transcranial Doppler：a stethoscope for the brain-neurocritical care use[J]. J Neurosci Res，2018，96（4）：720-730.

[20] XU W H，WANG H，WANG B，et al. Disparate cardio-cerebral vascular modulation during standing in multiple system atrophy and Parkinson disease[J]. J Neurol Sci，2009，276（1/2）：84-87.

[21] 蔡华彬，范文捷，熊亦璇，等. 轻型急性缺血性卒中患者TCD卧立位试验与其预后的相关性研究[J]. 临床神经病学杂志，2022，35（5）：355-358.

CAI H B，FAN W J，XIONG Y X，et al. Association between supine-to-standing TCD test and prognosis in patients with mild acute ischemic stroke[J]. J Clin Neurol，2022，35（5）：355-358.

[22] PENG S J，CHEN Y W，YANG J Y，et al. Automated cerebral infarct detection on computed tomography images based on deep learning[J/OL]. Biomedicines，2022，10（1）：122[2024-08-01]. https://doi.org/10.3390/biomedicines10010122.

[23] LI B，LIU G P. Magnetic resonance imaging image segmentation under artificial intelligence neural network for evaluation of the effect of butyphthalide combined with edaravone on neurological function in patients with acute cerebral infarction[J/OL]. Front Neurorobot，2021，15：719145[2024-08-01]. https://doi.org/10.3389/fnbot.2021.719145.

[24] MURRAY N M，UNBERATH M，HAGER G D，et al. Artificial intelligence to diagnose ischemic stroke and identify large vessel occlusions：a systematic review[J]. J Neurointerv Surg，2020，12（2）：156-164.

[25] MAINALI S，DARSIE M E，SMETANA K S. Machine learning in action：stroke diagnosis and outcome prediction[J/OL]. Front Neurol，2021，12：734345[2024-08-01]. https://doi.org/10.3389/fneur.2021.734345.

[26] CHEN Y J，SONG Y Y，HUANG J，et al. Increased circulating exosomal miRNA-223 is associated with acute ischemic stroke[J/OL]. Front Neurol，2017，8：57[2024-08-01]. https://doi.org/10.3389/fneur.2017.00057.

[27] OSTOLAZA A，BLANCO-LUQUIN I，URDáNOZ-CASADO A，et al. Circular RNA expression profile in blood according to ischemic stroke etiology[J/OL]. Cell Biosci，2020，10：34[2024-08-01]. https://doi.org/10.1186/s13578-020-00394-3.

[28] DOEHNER W，VON HAEHLING S，SUHR J，et al. Elevated plasma levels of neuropeptide proenkephalin A predict mortality and functional outcome in ischemic stroke[J]. J Am Coll Cardiol，2012，60（4）：346-354.

[29] GOYAL M，HILL M D，SAVER J L，et al. Challenges and opportunities of endovascular stroke therapy[J]. Ann Neurol，2016，79（1）：11-17.

[30] SAVER J L，GOYAL M，BONAFE A，et al. Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke[J]. N Engl J Med，2015，372（24）：2285-2295.

[31] ALBERS G W，MARKS M P，KEMP S，et al. Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging[J]. N Engl J Med，2018，378（8）：708-718.

[32] NOGUEIRA R G，JADHAV A P，HAUSSEN D C，et al. Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct[J]. N Engl J Med，2018，378（1）：11-21.

[33] TURK A S，3rd，SIDDIQUI A，FIFI J T，et al. Aspiration thrombectomy versus stent retriever thrombectomy as first-line approach for large vessel occlusion（COMPASS）：a multicentre，randomised，open label，blinded outcome，non-inferiority trial[J]. Lancet，2019，393（10175）：998-1008.

[34] MA H，CAMPBELL B C V，PARSONS M W，et al. Thrombolysis guided by perfusion imaging up to 9 hours after onset of stroke[J]. N Engl J Med，2019，380（19）：1795-1803.

[35] HACKE W，DONNAN G，FIESCHI C，et al. Association of outcome with early stroke treatment：pooled analysis of ATLANTIS，ECASS，and NINDS rt-PA stroke trials[J]. Lancet，2004，363（9411）：768-774.

[36] LI S Y，GU H Q，LI H，et al. Reteplase versus alteplase for acute ischemic stroke[J]. N Engl J Med，2024，390（24）：2264-2273.

[37] XIONG Y Y，CAMPBELL B C V，SCHWAMM L H，et al. Tenecteplase for ischemic stroke at 4.5 to 24 hours without thrombectomy[J]. N Engl J Med，2024，391（3）：203-212.

[38] YAGHI S，WILLEY J Z，CUCCHIARA B，et al. Treatment and outcome of hemorrhagic transformation after intravenous alteplase in acute ischemic stroke：a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association[J/OL]. Stroke，2017，48（12）：e343-e361[2024-08-01]. https://doi.org/10.1161/STR.0000000000000152.

[39] LU X C，ZHANG J，DING Y，et al. Novel therapeutic strategies for ischemic stroke：recent insights into autophagy[J/OL]. Oxid Med Cell Longev，2022，2022：3450207[2024-08-01]. https://doi.org/10.1155/2022/3450207.

[40] LI G L，YE C S，ZHU Y，et al. Oxidative injury in ischemic stroke：a focus on NADPH oxidase 4[J/OL]. Oxid Med Cell Longev，2022，2022：1148874[2024-08-01]. https://doi.org/10.1155/2022/1148874.

[41] XU S B，LU J N，SHAO A W，et al. Glial cells：role of the immune response in ischemic stroke[J/OL]. Front Immunol，2020，11：294[2024-08-01]. https://doi.org/10.3389/fimmu.2020.00294.

[42] ZHANG Y，MA L H，REN C H，et al. Immediate remote ischemic postconditioning reduces cerebral damage in ischemic stroke mice by enhancing leptomeningeal collateral circulation[J]. J Cell Physiol，2019，234（8）：12637-12645.

[43] DOEPPNER T R，HERZ J，GÖRGENS A，et al. Extracellular vesicles improve post-stroke neuroregeneration and prevent postischemic immunosuppression[J]. Stem Cells Transl Med，2015，4（10）：1131-1143.

[44] DE KEYSER J. Autologous mesenchymal stem cell transplantation in stroke patients[J]. Ann Neurol，2005，58（4）：653-654.

[45] DEUS I A，MANO J F，CUSTóDIO C A. Perinatal tissues and cells in tissue engineering and regenerative medicine[J/OL]. Acta Biomater，2020，110：1-14[2024-08-01]. https://doi.org/10.1016/j.actbio.2020.04.035.

[46] NITO C，SUDA S，NITAHARA-KASAHARA Y，et al. Dental-pulp stem cells as a therapeutic strategy for ischemic stroke[J/OL]. Biomedicines，2022，10（4）：737[2024-08-01]. https://doi.org/10.3390/biomedicines10040737.

[47] PHAN T G，MA H，LIM R，et al. Phase 1 trial of amnion cell therapy for ischemic stroke[J/OL]. Front Neurol，2018，9：198[2024-08-01]. https://doi.org/10.3389/fneur.2018.00198.

[48] LI B，OUCHI T，CAO Y B，et al. Dental-derived mesenchymal stem cells：state of the art[J/OL]. Front Cell Dev Biol，2021，9：654559[2024-08-01]. https://doi.org/10.3389/fcell.2021.654559.

[49] LI C，SUN T，JIANG C. Recent advances in nanomedicines for the treatment of ischemic stroke[J]. Acta Pharm Sin B，2021，11（7）：1767-1788.

[50] KONG J L，CHU R X，WANG Y. Neuroprotective treatments for ischemic stroke：opportunities for nanotechnology[J/OL]. Adv Funct Mater，2022，32（52）：2209405[2024-08-01]. https://doi.org/10.1002/adfm.202209405.

[51] HAN Q，WANG C C，LIU J，et al. Application of nanozymes and its progress in the treatment of ischemic stroke[J]. Transl Stroke Res，2024，15（5）：880-892.

[52] ZHANG H Y，ZHAO Z Q，SUN S N，et al. Molecularly self-fueled nano-penetrator for nonpharmaceutical treatment of thrombosis and ischemic stroke[J/OL]. Nat Commun，2023，14（1）：255[2024-08-01]. https://doi.org/10.1038/s41467-023-35895-5.

[53] ZHAO Y，LI Q，NIU J Y，et al. Neutrophil membrane-camouflaged polyprodrug nanomedicine for inflammation suppression in ischemic stroke therapy[J/OL]. Adv Mater，2024，36（21）：e2311803[2024-08-01]. https://doi.org/10.1002/adma.202311803.